Catalyst Wire Dossier Catalyst Wire Dossier

SYMPAZAN

clobazam · Aquestive Therapeutics
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for SYMPAZAN, covering 2018-11-01 to 2024-03-12. Get the full timeline:

Most recent: FDA Approved: SYMPAZAN — Supplemental Application (Aquestive Therapeutics)

See pricing